Loading Events

« All Events

  • This event has passed.

Role of FDG-PET in Paediatric Hodgkin and Non-Hodgkin Lymphomas

June 27 09:00 June 28 17:00 CEST


UEMS EACCME has granted the accreditation of 8 CME credits for this event.

A large oncological framework will be the topic of the first session: three lectures by a high quoted Paediatric Oncologist: epidemiology, aetiological factors, and general classification of Paediatric Hodgkin and non-Hodgkin Lymphomas and main therapeutic strategies and prognostic considerations. The two valuable nuclear medicine experts will discuss the role of molecular imaging in paediatric lymphomas: staging and therapeutic management, the importance of the imaging-based assessment, the role of Deauville classification, prognostic aspects, surveillance, and the management of recurrent/treatment resistant forms in PHL and NHL. Current state of experimental tracers research. Future perspectives: novel radiotracers, evaluation of rare entities and advanced image analysis.

Many case readings will be presented to the attendees to train them in interpreting and concluding 18FDG in the crucial assessment point into diagnostic- therapeutic PHL and NHL protocols.

Each attendee is also asked to present a personal tricky case, proposed to the experts and to the other attendees. This allows better communication among the attendees and a more interactive practical session.

Save yourself a seat

The registration is closed. For last minute interest, contact esmit@eanm.org

Target Audience

  • Residents, NM specialist approaching paediatric ematology-oncology

Learning Objectives

  • The aim of this course is initially to refresh and update clinical setting from the point of view of the pediatric Oncologist: epidemiology, aetiological factors, and general classification of Pediatric Hodgkin and non-Hodgkin Lymphomas and main therapeutic strategies.
  • The two nuclear medicine experts will discuss the role of molecular imaging in paediatric lymphomas and about the importance of imaging-based assessment, and the role of Deauville classification in the main forms of PHL and NHL. 
  • The current state of experimental tracers research and future perspectives: novel radiotracers, evaluation of rare entities and advanced image analysis. Two interactive sessions with a lot of case reading to train the attendees in the evaluation, interpretation and comparison of 18FDG-PET-CT.  

Programme

Click to view the preliminary programme

Faculty

Marta Pillon

Speaker

Italy

Pinar Kiratli

Speaker

Türkiye

Francesco Fiz

Speaker

Italy

Registration Details

Course Fee               € 950.-

Registration Fee includes:

  • Electronic Course Book, including all Slides
  • Coffee Breaks on each Course Day
  • Lunch on first Course Day

Registration Fee does NOT include:

  • Travel to the Venue
  • Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Event Overview

€950 VAT included

ESMIT

View Organiser Website

Future Health Lab

Alfred-Adler-Straße 1
Vienna, 1100 Austria
+ Google Map